These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8978843)

  • 1. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5137-58. PubMed ID: 8978843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides.
    Draheim SE; Bach NJ; Dillard RD; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5159-75. PubMed ID: 8978844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbocyclic[g]indole inhibitors of human nonpancreatic s-PLA2.
    Sawyer JS; Beight DW; Smith EC; Snyder DW; Chastain MK; Tielking RL; Hartley LW; Carlson DG
    J Med Chem; 2005 Feb; 48(3):893-6. PubMed ID: 15689175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2.
    Schevitz RW; Bach NJ; Carlson DG; Chirgadze NY; Clawson DK; Dillard RD; Draheim SE; Hartley LW; Jones ND; Mihelich ED
    Nat Struct Biol; 1995 Jun; 2(6):458-65. PubMed ID: 7664108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).
    Bridonneau P; Chang YF; O'Connell D; Gill SC; Snyder DW; Johnson L; Goodson T; Herron DK; Parma DH
    J Med Chem; 1998 Mar; 41(6):778-86. PubMed ID: 9526554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity.
    Hansford KA; Reid RC; Clark CI; Tyndall JD; Whitehouse MW; Guthrie T; McGeary RP; Schafer K; Martin JL; Fairlie DP
    Chembiochem; 2003 Mar; 4(2-3):181-5. PubMed ID: 12616631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular modeling and 3D QSAR study of a large series of indole inhibitors of human non-pancreatic secretory phospholipase A2.
    Bernard P; Pintore M; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):1-19. PubMed ID: 11231045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A2.
    Pintore M; Bernard P; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):21-30. PubMed ID: 11231046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically induced dimerization of human nonpancreatic secretory phospholipase A2 by bis-indole derivatives.
    Zhou L; Fang C; Wei P; Liu S; Liu Y; Lai L
    J Med Chem; 2008 Jun; 51(12):3360-6. PubMed ID: 18522384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.
    Scott DL; White SP; Browning JL; Rosa JJ; Gelb MH; Sigler PB
    Science; 1991 Nov; 254(5034):1007-10. PubMed ID: 1948070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,3-Dioxane-4,6-dione-5-carboxamide-based inhibitors of human group IIA phospholipase A: X-ray structure of the complex and interfacial selection of inhibitors from a structural library.
    Bryant MD; Flick KE; Koduri RS; Wilton DC; Stoddard BL; Gelb MH
    Bioorg Med Chem Lett; 1999 Apr; 9(8):1097-102. PubMed ID: 10328292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 14-kDa PLA2 by 2-acylamino-alkylphospholipids: the influence of amide acidity.
    Kley JT; Unger C; Massing U
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):193-201. PubMed ID: 9630626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
    Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
    J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SB-253514 and analogues: novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. II. Physico-chemical properties and structure elucidation.
    Busby DJ; Copley RC; Hueso JA; Readshaw SA; Rivera A
    J Antibiot (Tokyo); 2000 Jul; 53(7):670-6. PubMed ID: 10994808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
    Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
    Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.
    Teshirogi I; Matsutani S; Shirahase K; Fujii Y; Yoshida T; Tanaka K; Ohtani M
    J Med Chem; 1996 Dec; 39(26):5183-91. PubMed ID: 8978846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX).
    Cha SS; Lee D; Adams J; Kurdyla JT; Jones CS; Marshall LA; Bolognese B; Abdel-Meguid SS; Oh BH
    J Med Chem; 1996 Sep; 39(20):3878-81. PubMed ID: 8831753
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of secretory phospholipase A2. 2-Synthesis and structure-activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme.
    Dong CZ; Ahamada-Himidi A; Plocki S; Aoun D; Touaibia M; Meddad-Bel Habich N; Huet J; Redeuilh C; Ombetta JE; Godfroid JJ; Massicot F; Heymans F
    Bioorg Med Chem; 2005 Mar; 13(6):1989-2007. PubMed ID: 15727853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling in the design of phospholipase A2 inhibitors.
    Ripka WC; Sipio WJ; Galbraith WG
    J Cell Biochem; 1989 Jul; 40(3):279-86. PubMed ID: 2777907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.